HLNT, ICNB, NOK, TLON, ASKE & Extended Watchlist

Highline Technical Innovations. Inc HLNT

HLNT has appeared on our watchlist in the past, and is sporting one heck of a chart. HLNT pushed to a new high yesterday on twice the average 3mo. volume; this stock has entered blue-sky breakout territory.

As you can plainly see on the chart, HLNT has absolutely been on fire. The last time this appeared on our watchlist was July 2nd, at which time the stock was as low as .0046.

Recent News:

USA based Delta Electronics named premier manufacturer for Hy-Impact™ fuel saving and emissions reducing intelligent hydrogen systems


ICNB had its third consecutive day of gains since we’ve been following it last Thursday.

Having been as low as .022 since that time, the stock has been making higher highs and higher lows. Yesterday the high reached .089, for a posible gain of 305%


Nokia Corp. NOK

Nokia is another one that we began mentioning Thursday’s Extended Watchlist, after the stock had recently seen its 52-wk low. NOK has been gapping up 2-5% each day we’ve had it on our radar, and today seems no exception.

Key resistance should come at the 50DMA of 2.33, and if a break above that point occurs, we could see substantially more gains than the recovery process here has already provided.


Talon Therapeutics, Inc. TLON

We’ve covered TLON since July 11th. At the time we stated “TLON is likely to become a target for many investors as we approach August 12, the company’s FDA PDUFA for their Phase III drug candidate Marqibo.” The stock was trading at 1.28.

At yesterday’s high of 1.83, we were up 43%


Alaska Pacific Energy Corp. ASKE

This play, new to our newsletter yesterday, managed a possible gain of 100%, after seeing a low of .0002, and subsequently closing at .0004.

That’s an unbelievably positive first-day showing.


Extended Watchlist:

AH, BBDA, AAPT, IMDS, AAPL $605 & $610 Calls (In the event APPL can return to $615 or higher, those calls will be well in the money.)

BBDA, AAPT & Today’s Extended Watchlist

Bebida Beverage Co. BBDA

BBDA has been holding support at the 20DMA (.0025).We are now looking for a break of .003. The next major resistance comes at the previous high of .0039. We like that it has been trading in a tight channel between .0025 and .003.

This stock has been on our radar for some time now, and will remain there for the foreseeable future.


All American Pet Company, Inc. AAPT

AAPT has been hovering around the .018-.023 range for the past couple of weeks.

The chart on AAPT indicates a crossing PPO. Should the stock manage to break the 20DMA (.0221) & 100DMA ( .0266), there’s a chance that the stock might make a run at the 50DMA of .0341.

We like this stock, as well as the company and products behind it, and will continue to monitor it going forward.


Extended Watchlist:

ICNB, AMRN, AKS & Today’s Extended Watchlist

We try to bring you a nice selection of quality picks on a daily basis, and believe us, we are well aware of our competition. There simply isn’t another stock newsletter out there that has our level of continual success, coupled with concern for our readers’ success. Anywhere.


Iconic Brands, Inc. ICNB

Take ICNB for instance. We put this forth yesterday as a momentum play, and after touching a low of .022, the stock surged ahead, closing at .055. Total possible single-session gains: 150%


Amarin Corp. Plc AMRN

Despite receiving FDA approval for their new drug, AMRN appears to be gapping down this morning. After all of the hype and baked-in PPS leading into the approval date, it appears the stock now wants consolidate. Excessive profit-taking in these instances can hold back the progress of a stock, so we will be observing for any possible bounces.

BEDMINSTER, N.J. and DUBLIN, Ireland, July 26, 2012 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the U.S. Food and Drug Administration (FDA) has approved Vascepa(TM) (icosapent ethyl) capsules (formerly known as AMR101) as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (TG greater than or equal to 500mg/dL) hypertriglyceridemia (very high triglycerides).


AK Steel Holding Corp. AKS  &  Arch Coal, Inc. ACI

On June 18th, we alerted ACI as a bottom-fishers dream, and the stock subsequently ran from a low of 5.41 to 7.63 for a gain of 41% The stock saw a new low yesterday (5.16), and again seems like a good one to watch for a possible upcoming bounce.

AKS is exhibiting some similar characteristics to ACI. The charts are alike in many ways, and like ACI, AKS is hovering around a bottom. Therefore, we want to keep an eye on it moving forward, in the event that it matches the kind of bounce we saw in ACI.


Extended Watchlist: